{"symbol":"PFE","fiscalQuarter":"Q3-2025","reportDate":"2025-11-04","reportTime":"BMO","status":"reported","company":{"name":"Pfizer Inc.","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/PFE/earnings/Q3-2025","postBrief":{"headline":"Pfizer Beats on EPS, Stock Down 1.46%","keyNumbers":[{"metric":"EPS","actual":"$0.87","expected":"N/A","surprise":"+32.22%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing efforts in research and development.","They expressed confidence in the pipeline but acknowledged market challenges.","The focus remains on long-term growth despite current pressures."],"summary":"Overall, management conveyed a cautious optimism about future projects. They emphasized the importance of their R&D initiatives while recognizing external challenges."},"guidanceChanges":{"summary":"No forward guidance was provided during this earnings call.","changes":[]},"whatItMeans":"Pfizer's earnings report showed a strong EPS performance, beating expectations significantly. However, the stock reacted negatively, declining by 1.46%, likely due to the lack of revenue details and guidance. Investors may be concerned about the company's future prospects without clear direction.","metaDescription":"Pfizer Inc (PFE) Q3 2025 earnings: EPS beat by 32.22%, revenue not disclosed. Stock down 1.46%. Full breakdown."}}